Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications.

[1]  Joe Y. Chang,et al.  Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". , 2014, International journal of radiation oncology, biology, physics.

[2]  J. Sonke,et al.  Substantial Dose-response Relationship with Clinical Outcome for Lung Stereotactic Body Radiotherapy (SBRT) Delivered via Online Image Guidance , 2010 .

[3]  P. Smith.  No-fly zone. , 2014 .

[4]  C. Faivre-Finn,et al.  Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): solid evidence or "no-go"? , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Suresh Senan,et al.  Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Peter Balter,et al.  Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer , 2012, Radiation oncology.

[7]  L. Wilson,et al.  Stereotactic Body Radiotherapy for Central Lung Tumors , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  Joe Y. Chang,et al.  Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[9]  P. Parikh,et al.  Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  Shafak Aluwini,et al.  Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  John Cho,et al.  Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. , 2012, International journal of radiation oncology, biology, physics.

[12]  S. Senan,et al.  Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  Joe Y. Chang,et al.  Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. , 2011, International journal of radiation oncology, biology, physics.

[14]  Peter A S Johnstone,et al.  Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver. , 2011, International journal of radiation oncology, biology, physics.

[15]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[16]  E. Vokes,et al.  Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Peter A S Johnstone,et al.  Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Seong Soo Shin,et al.  Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. , 2009, Lung cancer.

[19]  Tarek Mekhail,et al.  A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  M. Schell,et al.  Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Joe Y. Chang,et al.  Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[22]  Lech Papiez,et al.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Ping Li,et al.  Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.

[24]  T. Araki,et al.  Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.

[25]  R. Sutherland,et al.  On the nature of the radiobiologically hypoxic fraction in tumors. , 1980, International journal of radiation oncology, biology, physics.